crohn's glp 1 glp-1 and disease New research published in the Foundation's journal Crohn's & Colitis 360 GLP-1 Medications: Reimagining the Treatment

commercial health claims data covering over 50 million insured individuals - including 139,000 GLP-1 users from 2022 to 2024 - our findings reveal powerful insights: Cost Savings:In their second year, GLP-1 users showed a 7% improvement in the growth of medical spend - a strong indicator of potential long-term savings for employers

A Potent Blend of resistant starch from green banana powder, Nufiber resistant dextrin, and beta-glucans for a powerful fiber gut boost

Frequently Asked Questions Why is GLP-1 face more common for those over the age of 40

Combat "Ozempic Face" with customized treatments

Lemon balm extract supports the gut-brain axis, helping reduce stress-related digestive discomfort for complete digestive wellness